文献速递腹部介入US

超声造影在局灶性肝脏病变活检中的获益:820例回顾性研究

The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases.
PubMed 文献 · Eur Radiol · 2022-07-26

该单中心回顾性研究纳入2017至2019年820例局灶性肝脏病变经皮肝活检患者,按活检前采用超声(362例)或超声造影(458例)引导分组比较。超声造影组标本可接受率、诊断准确率和敏感度均优于超声组,在病变≥5 cm、不均匀低回声或边界不清的局灶性肝脏病变中优势更明显。

要点

  • 超声造影引导肝活检的标本可接受率97.6% vs 99.4%,诊断准确率92.6% vs 96.4%,敏感度92.5% vs 96.2%,均优于超声引导。
  • 病变≥5 cm、不均匀低回声或边界不清的局灶性肝脏病变,超声造影引导优势更明显。
  • 单次穿刺活检准确率100% vs 92.7%,穿刺≤2次准确率97.6% vs 94.3%,超声造影组均更高。

核心结论

  • 超声造影可提高肝活检取材成功率和诊断准确率,尤其适用于≥5 cm、不均匀低回声或边界不清的局灶性肝脏病变,并可减少穿刺次数从而可能提高安全性。

研究设计与样本

  • 单中心回顾性研究,纳入2017至2019年820例局灶性肝脏病变经皮肝活检患者,按活检前采用超声(n=362)或超声造影(n=458)引导分为两组,比较标本可接受率和诊断准确率,并按病变及方案特征进行分层分析。

诊断标准与关键数值

  • 超声造影组 vs 超声组标本可接受率99.4% vs 97.6%(p<0.05)。
  • 超声造影组 vs 超声组诊断准确率96.4% vs 92.6%(p<0.05)。
  • 超声造影组 vs 超声组活检敏感度96.2% vs 92.5%(p<0.05)。
  • 单次穿刺活检准确率超声造影组100% vs 超声组92.7%(p<0.05)。
  • 穿刺≤2次活检准确率超声造影组97.6% vs 超声组94.3%(p<0.05)。

临床应用与阅片要点

  • 作者推荐对局灶性肝脏病变肝活检使用超声造影引导,尤其是病变≥5 cm、不均匀低回声或边界不清时。
  • 超声造影可帮助确认合适的活检部位,提高取材成功率和诊断准确率。
  • 超声造影可减少所需穿刺次数,可能提高肝活检的安全性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study compared the performance between ultrasound (US)- and contrast-enhanced US (CEUS)-guided liver biopsies and evaluated the benefit of CEUS in percutaneous biopsy for focal liver lesions (FLLs).

METHODS: We performed a retrospective study of 820 patients with FLLs, who underwent percutaneous liver biopsy in our center between 2017 and 2019. The patients were divided into two groups based on whether US (n = 362) or CEUS (n = 458) used before a biopsy. The two groups were compared based on specimen adequacy for pathological diagnosis and diagnostic accuracy of liver biopsy. Stratification analysis was performed based on lesion and protocol characteristics to provide detailed information for selecting the imaging guidance for biopsy.

RESULTS: Compared with the US group, the CEUS group yielded more acceptable samples (97.6% vs. 99.4%, p < 0.05) and improved diagnostic accuracy (92.6% vs. 96.4%, p < 0.05), and achieved better sensitivity (92.5% vs. 96.2%, p < 0.05) for liver biopsies, especially in FLLs ≥ 5 cm, heterogeneous hypoechoic FLLs, or FLLs with an obscure boundary. The CEUS group showed significantly higher accuracy compared with the US group pertaining to single-puncture biopsies (100% vs. 92.7%, p < 0.05) or biopsies with punctures ≤ 2 (97.6% vs. 94.3%, p < 0.05).

CONCLUSION: CEUS achieved an enhanced success rate for sampling and diagnostic accuracy of liver biopsies, especially in FLLs ≥ 5 cm, heterogeneous hypoechoic FLLs, or FLLs with an obscure boundary. CEUS can be used to decrease the number of punctures needed, which might increase the safety of liver biopsy.

KEY POINTS: • CEUS can help confirm an adequate biopsy site, increasing the sampling success rate and diagnostic accuracy of the liver biopsy. • CEUS can be used to decrease the number of punctures needed to improve the safety of liver biopsy. • It is recommended to use CEUS guidance for liver biopsies, especially with FLLs ≥ 5 cm, heterogeneous hypoechoic FLLs, or FLLs with an obscure boundary.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Huang, Shi, Xu, et al. The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases. Eur Radiol. 2022. PMID: 35881185. doi:10.1007/s00330-022-08988-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。